Angelo Camporeale

644 total citations
16 papers, 470 citations indexed

About

Angelo Camporeale is a scholar working on Psychiatry and Mental health, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Angelo Camporeale has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 3 papers in Surgery and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Angelo Camporeale's work include Migraine and Headache Studies (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Angelo Camporeale is often cited by papers focused on Migraine and Headache Studies (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Angelo Camporeale collaborates with scholars based in United States, Italy and Spain. Angelo Camporeale's co-authors include D. Agnusdei, Tina M. Oakes, Virginia L. Stauffer, Vladimir Skljarevski, Shufang Wang, David Kudrow, Katherine J. Selzler, Annelies Van Dycke, Qi Zhang and Aaron L. Schacht and has published in prestigious journals such as Neurology, Calcified Tissue International and JAMA Neurology.

In The Last Decade

Angelo Camporeale

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Camporeale United States 11 383 236 109 55 50 16 470
Iris E. Verhagen Netherlands 12 352 0.9× 176 0.7× 106 1.0× 8 0.1× 32 0.6× 18 469
Fethi İdiman Türkiye 11 229 0.6× 203 0.9× 86 0.8× 20 0.4× 35 0.7× 25 470
Nanna Arngrim Denmark 16 426 1.1× 189 0.8× 173 1.6× 66 1.2× 82 1.6× 25 725
Emmanuele Tafuri Italy 7 243 0.6× 73 0.3× 136 1.2× 56 1.0× 80 1.6× 9 530
Lawrence Robbins United States 10 391 1.0× 221 0.9× 149 1.4× 15 0.3× 37 0.7× 23 452
Katharina Kamm Germany 10 518 1.4× 320 1.4× 195 1.8× 13 0.2× 42 0.8× 26 640
B. Lee Peterlin United States 6 240 0.6× 118 0.5× 90 0.8× 32 0.6× 32 0.6× 10 383
V. Tullo Italy 15 434 1.1× 319 1.4× 206 1.9× 39 0.7× 50 1.0× 54 608
Rebecca Gavett United States 5 127 0.3× 628 2.7× 33 0.3× 82 1.5× 9 0.2× 6 744
Luca Giani Italy 11 269 0.7× 146 0.6× 110 1.0× 49 0.9× 23 0.5× 43 355

Countries citing papers authored by Angelo Camporeale

Since Specialization
Citations

This map shows the geographic impact of Angelo Camporeale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Camporeale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Camporeale more than expected).

Fields of papers citing papers by Angelo Camporeale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Camporeale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Camporeale. The network helps show where Angelo Camporeale may publish in the future.

Co-authorship network of co-authors of Angelo Camporeale

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Camporeale. A scholar is included among the top collaborators of Angelo Camporeale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Camporeale. Angelo Camporeale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stauffer, Virginia L., Shufang Wang, Jo Bonner, et al.. (2020). Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine. BMC Neurology. 20(1). 194–194. 4 indexed citations
2.
Stauffer, Virginia L., Ira Turner, William Kielbasa, et al.. (2020). Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials. The Journal of Headache and Pain. 21(1). 79–79. 12 indexed citations
3.
4.
5.
Camporeale, Angelo, David Kudrow, Shufang Wang, et al.. (2018). A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine. BMC Neurology. 18(1). 188–188. 105 indexed citations
6.
Oakes, Tina M., Vladimir Skljarevski, Qi Zhang, et al.. (2018). Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study. Cephalalgia. 38(6). 1015–1025. 41 indexed citations
7.
Regev, Arie, Angelo Camporeale, Vladimir Skljarevski, Shufang Wang, & Jeff Carter. (2017). Hepatic safety of galcanezumab in patients with migraine: Results of three Phase 2 double-blind placebo-controlled trials (P2.164). Neurology. 88(16_supplement). 2 indexed citations
8.
Skljarevski, Vladimir, Tina M. Oakes, Qi Zhang, et al.. (2017). Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention. JAMA Neurology. 75(2). 187–187. 124 indexed citations
9.
Upadhyaya, Himanshu P., Christopher J. Kratochvil, Jaswinder K. Ghuman, et al.. (2014). Efficacy and Safety Extrapolation Analyses for Atomoxetine in Young Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 25(10). 799–809. 10 indexed citations
10.
11.
Camporeale, Angelo, et al.. (2013). Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis. Drug Safety. 36(8). 663–671. 18 indexed citations
12.
Upadhyaya, Himanshu P., Josep Antoni Ramos‐Quiroga, Lenard A. Adler, et al.. (2013). Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study. The European Journal of Psychiatry. 27(3). 185–205. 27 indexed citations
13.
Camporeale, Angelo, Himanshu P. Upadhyaya, Josep Antoni Ramos‐Quiroga, et al.. (2013). Safety and tolerability of atomoxetine hydrochloride in a long-term, placebo-controlled randomized withdrawal study in European and non-European adults with attention-deficit/hyperactivity disorder. The European Journal of Psychiatry. 27(3). 206–224. 11 indexed citations
14.
15.
Agnusdei, D., et al.. (1991). Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcified Tissue International. 49(S2). S9–S13. 58 indexed citations
16.
Agnusdei, D., Roberto Civitelli, Angelo Camporeale, & C. Gennari. (1988). Paget bone disease and heredity: a case report.. PubMed. 36(3). 150–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris E. Verhagen Breakdown of academic impact, for papers by Fethi İdiman Breakdown of academic impact, for papers by Nanna Arngrim Breakdown of academic impact, for papers by Emmanuele Tafuri Breakdown of academic impact, for papers by Lawrence Robbins Breakdown of academic impact, for papers by Katharina Kamm Breakdown of academic impact, for papers by B. Lee Peterlin Breakdown of academic impact, for papers by V. Tullo Breakdown of academic impact, for papers by Rebecca Gavett Breakdown of academic impact, for papers by Luca Giani
Rankless by CCL
2026